Brief: Kinnate Biopharma Announces Addition To Nasdaq Biotechnology Index
16/12/2021 22:35
Dec 16 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. ANNOUNCES ADDITION TO NASDAQ
BIOTECHNOLOGY INDEX
* KINNATE BIOPHARMA INC - ADDITION TO NBI WILL BECOME
EFFECTIVE
PRIOR TO MARKET OPEN ON MONDAY, DECEMBER 20, 2021
Source text for Eikon: ID:nGNX8Xrkdz
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview